Cytophenix

Cytophenix is developing rapid antimicrobial susceptibility tests that offer accurate and timely results, with the mission of enhancing treatment recommendations for patients with serious life-threatening infections. Cytophenix’s innovative approach expedites the testing process without compromising accuracy. By swiftly identifying the most effective antibiotics for individual patients, informed treatment decisions can be made sooner. With a team of seasoned researchers, clinicians, and engineers, Cytophenix is committed to transforming patient care by reducing the time to tailored treatment recommendations. By improving the speed and accuracy of antimicrobial susceptibility testing, Cytophenix is poised to make a significant impact on the management of serious infections, saving lives and optimising patient outcomes.